130 related articles for article (PubMed ID: 26074400)
1. Association between Int7G24A rs334354 polymorphism and cancer risk: a meta-analysis of case-control studies.
Wu W; Tong Y; Wei X; Zhao Q; Pan X; Yu G; Lu Q
Sci Rep; 2015 Jun; 5():11350. PubMed ID: 26074400
[TBL] [Abstract][Full Text] [Related]
2. Int7G24A variant of transforming growth factor-beta receptor 1 is associated with osteosarcoma susceptibility in a Chinese population.
Hu YS; Pan Y; Li WH; Zhang Y; Li J; Ma BA
Med Oncol; 2011 Jun; 28(2):622-5. PubMed ID: 20354825
[TBL] [Abstract][Full Text] [Related]
3. Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer.
Chen T; Jackson CR; Link A; Markey MP; Colligan BM; Douglass LE; Pemberton JO; Deddens JA; Graff JR; Carter JH
Clin Cancer Res; 2006 Jan; 12(2):392-7. PubMed ID: 16428477
[TBL] [Abstract][Full Text] [Related]
4. Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma.
Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G
Mol Biol Rep; 2012 Apr; 39(4):4301-9. PubMed ID: 21785915
[TBL] [Abstract][Full Text] [Related]
5. TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.
Song B; Margolin S; Skoglund J; Zhou X; Rantala J; Picelli S; Werelius B; Lindblom A
Br J Cancer; 2007 Oct; 97(8):1175-9. PubMed ID: 17848956
[TBL] [Abstract][Full Text] [Related]
6. Int7G24A polymorphism (rs334354) and cancer risk.
Liu X; Shan Y; Xue B
Arch Med Sci; 2013 Feb; 9(1):3-7. PubMed ID: 23515707
[TBL] [Abstract][Full Text] [Related]
7. Int7G24A variant of the TGFBR1 gene and cancer risk: a meta-analysis of three case-control studies.
Zhang HT
Lung Cancer; 2005 Sep; 49(3):419-20. PubMed ID: 15955593
[No Abstract] [Full Text] [Related]
8. Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies.
Wang YQ; Qi XW; Wang F; Jiang J; Guo QN
PLoS One; 2012; 7(8):e42899. PubMed ID: 22905183
[TBL] [Abstract][Full Text] [Related]
9. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
[TBL] [Abstract][Full Text] [Related]
10. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
[TBL] [Abstract][Full Text] [Related]
11. The association of polymorphisms on TGFBR1 and colorectal cancer risk: a meta-analysis.
Zhang X; Wu L; Sheng Y; Zhou W; Huang Z; Qu J; Gao G; Cai D; Zhang M
Mol Biol Rep; 2012 Mar; 39(3):2567-74. PubMed ID: 21858550
[TBL] [Abstract][Full Text] [Related]
12. The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.
Colleran G; McInerney N; Rowan A; Barclay E; Jones AM; Curran C; Miller N; Kerin M; Tomlinson I; Sawyer E
Breast Cancer Res Treat; 2010 Jan; 119(2):437-42. PubMed ID: 19390964
[TBL] [Abstract][Full Text] [Related]
13. The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study.
Castillejo A; Mata-Balaguer T; Guarinos C; Castillejo MI; Martínez-Cantó A; Barberá VM; Montenegro P; Ochoa E; Lázaro R; Guillén-Ponce C; Carrato A; Soto JL
BMC Cancer; 2009 Nov; 9():406. PubMed ID: 19930569
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of transforming growth factor β receptor I 6A/9A gene polymorphism and breast cancer risk: the picture remains murky.
Ou C; Li H; Liu JH; Drummen GP; Zhu B; Huang LS; Huang Y; Li LQ
Biomarkers; 2015; 20(6-7):487-94. PubMed ID: 26616150
[TBL] [Abstract][Full Text] [Related]
15. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.
Kaklamani VG; Hou N; Bian Y; Reich J; Offit K; Michel LS; Rubinstein WS; Rademaker A; Pasche B
J Clin Oncol; 2003 Sep; 21(17):3236-43. PubMed ID: 12947057
[TBL] [Abstract][Full Text] [Related]
16. TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk.
Skoglund Lundin J; Vandrovcova J; Song B; Zhou X; Zelada-Hedman M; Werelius B; Houlston RS; Lindblom A
Br J Cancer; 2009 May; 100(10):1674-9. PubMed ID: 19401691
[TBL] [Abstract][Full Text] [Related]
17. An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder.
Chen T; Jackson C; Costello B; Singer N; Colligan B; Douglass L; Pemberton J; Deddens J; Graff JR; Carter JH
Int J Cancer; 2004 Nov; 112(3):420-5. PubMed ID: 15382067
[TBL] [Abstract][Full Text] [Related]
18. Genetic variations in the TGFβ signaling pathway, smoking and risk of colorectal cancer in a Chinese population.
Zhong R; Liu L; Zou L; Sheng W; Zhu B; Xiang H; Chen W; Chen J; Rui R; Zheng X; Yin J; Duan S; Yang B; Sun J; Lou J; Liu L; Xie D; Xu Y; Nie S; Miao X
Carcinogenesis; 2013 Apr; 34(4):936-42. PubMed ID: 23275154
[TBL] [Abstract][Full Text] [Related]
19. Association between the TGFBR2 G-875A polymorphism and cancer risk: evidence from a meta-analysis.
Huang YS; Zhong Y; Yu L; Wang L
Asian Pac J Cancer Prev; 2014; 15(20):8705-8. PubMed ID: 25374194
[TBL] [Abstract][Full Text] [Related]
20. Association between ANKK1 (rs1800497) polymorphism of DRD2 gene and attention deficit hyperactivity disorder: a meta-analysis.
Pan YQ; Qiao L; Xue XD; Fu JH
Neurosci Lett; 2015 Mar; 590():101-5. PubMed ID: 25641135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
